Stage 1 ET is manageable with early intervention, lifestyle changes, and treatments like low-dose aspirin and cytoreductive therapy to reduce clotting risk. Meta: Stage 1 essential thrombocythemia is ...

Essential thrombocythemia (ET) is a rare condition affecting the bone marrow, resulting in an overproduction of platelets. It usually affects those over the age of 50, progresses slowly, and can be ...

Centering their discussion on cornerstone therapies, expert hematologist-oncologists consider the treatment paradigms of essential thrombocythemia and polycythemia vera. Rami Komrokji, M.D.: Once we ...

A recent study identified trends in blood counts, but did not find statistically significant associations between achieving hematological remission and clinical outcomes in polycythemia vera (PV) or ...

Over the past 15 years, experts have expressed concern about the accurate diagnosis of polycythemia vera (PV), particularly in early stage disease. The World Health Organization (WHO) and the British ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/k62zdw/essential) has announced the addition of the "Essential ...

To our knowledge, in pediatric ET there is no information about in vitro cultures of megakaryocytic progenitors (CFU-MK) and it is scanty in erythroid (BFU-E) and granulomonocytic progenitors (CFU-GM) ...

DEAR DR. ROACH: Recently, I was diagnosed with essential thrombocythemia. The recommended treatment is the drug hydroxyurea because I turned 60 this past year and have a mutation in the JAK 2 gene. If ...

Findings showed 42.9% of P1101-treated patients achieved durable responses at both 9 and 12 months compared with 6% in those treated with anagrelide (P =.0001). Topline data were announced from a ...

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study After a median ...

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study The Oncology Grand ...